1. Home
  2. ALRN vs PRPL Comparison

ALRN vs PRPL Comparison

Compare ALRN & PRPL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALRN
  • PRPL
  • Stock Information
  • Founded
  • ALRN 2001
  • PRPL 2010
  • Country
  • ALRN United States
  • PRPL United States
  • Employees
  • ALRN N/A
  • PRPL N/A
  • Industry
  • ALRN Biotechnology: Pharmaceutical Preparations
  • PRPL Home Furnishings
  • Sector
  • ALRN Health Care
  • PRPL Consumer Discretionary
  • Exchange
  • ALRN Nasdaq
  • PRPL Nasdaq
  • Market Cap
  • ALRN 76.9M
  • PRPL 90.3M
  • IPO Year
  • ALRN 2017
  • PRPL N/A
  • Fundamental
  • Price
  • ALRN $1.97
  • PRPL $0.95
  • Analyst Decision
  • ALRN Strong Buy
  • PRPL Buy
  • Analyst Count
  • ALRN 1
  • PRPL 4
  • Target Price
  • ALRN $19.00
  • PRPL $2.53
  • AVG Volume (30 Days)
  • ALRN 137.2K
  • PRPL 434.4K
  • Earning Date
  • ALRN 11-14-2024
  • PRPL 03-11-2025
  • Dividend Yield
  • ALRN N/A
  • PRPL N/A
  • EPS Growth
  • ALRN N/A
  • PRPL N/A
  • EPS
  • ALRN N/A
  • PRPL N/A
  • Revenue
  • ALRN N/A
  • PRPL $504,838,000.00
  • Revenue This Year
  • ALRN N/A
  • PRPL N/A
  • Revenue Next Year
  • ALRN N/A
  • PRPL $2.21
  • P/E Ratio
  • ALRN N/A
  • PRPL N/A
  • Revenue Growth
  • ALRN N/A
  • PRPL N/A
  • 52 Week Low
  • ALRN $1.61
  • PRPL $0.69
  • 52 Week High
  • ALRN $7.42
  • PRPL $2.33
  • Technical
  • Relative Strength Index (RSI)
  • ALRN 41.44
  • PRPL 58.20
  • Support Level
  • ALRN $1.90
  • PRPL $0.79
  • Resistance Level
  • ALRN $2.17
  • PRPL $1.03
  • Average True Range (ATR)
  • ALRN 0.18
  • PRPL 0.08
  • MACD
  • ALRN 0.02
  • PRPL 0.02
  • Stochastic Oscillator
  • ALRN 23.27
  • PRPL 71.00

About ALRN Aileron Therapeutics Inc.

Aileron Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on developing a novel class of therapeutics for the treatment of cancer and other diseases. The company's lead product candidate, ALRN-6924 is a novel chemoprotective medicine to treat and protect healthy cells in patients with cancer that harbors p53 mutations to reduce or eliminate chemotherapy-induced side effects. The company currently has two product candidates in clinical development, LTI-03 and LTI-01, and multiple candidates in preclinical development focused on fibrosis indications.

About PRPL Purple Innovation Inc.

Purple Innovation Inc is a comfort innovation company. The company designs, manufactures and sells a range of comfort technology offerings, including mattresses, a pillow, cushions, sheets, bed platforms, and other products. It sells its products through online channels, traditional wholesale partners and third-party online retailers.

Share on Social Networks: